U.S. Capital Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1M Buy
17,474
+8,863
+103% +$8.99M 0.4% 56
2025
Q4
$9.25M Sell
8,611
-595
-6% -$569K 0.24% 102
2025
Q3
$7.02M Sell
9,206
-2,781
-23% -$2.07M 0.19% 133
2025
Q2
$9.34M Buy
11,987
+3,342
+39% +$2.6M 0.27% 91
2025
Q1
$7.14M Sell
8,645
-11,531
-57% -$9.59M 0.22% 121
2024
Q4
$15.6M Buy
20,176
+11,556
+134% +$9.57M 0.48% 43
2024
Q3
$7.64M Buy
8,620
+631
+8% +$567K 0.27% 81
2024
Q2
$7.23M Buy
7,989
+114
+1% +$91.2K 0.27% 83
2024
Q1
$6.13M Buy
7,875
+830
+12% +$591K 0.24% 103
2023
Q4
$4.11M Sell
7,045
-525
-7% -$306K 0.16% 135
2023
Q3
$4.07M Sell
7,570
-210
-3% -$108K 0.18% 120
2023
Q2
$3.65M Buy
7,780
+713
+10% +$299K 0.17% 124
2023
Q1
$2.43M Buy
7,067
+146
+2% +$49.2K 0.11% 175
2022
Q4
$2.53M Buy
6,921
+887
+15% +$314K 0.12% 169
2022
Q3
$1.95M Sell
6,034
-92
-2% -$29.1K 0.1% 192
2022
Q2
$1.99M Buy
6,126
+331
+6% +$99.4K 0.09% 218
2022
Q1
$1.66M Buy
5,795
+56
+1% +$14.4K 0.06% 306
2021
Q4
$1.58M Buy
5,739
+60
+1% +$15.2K 0.06% 310
2021
Q3
$1.31M Buy
+5,679
New +$1.4M 0.06% 333

Other funds holding LLY

U.S. Capital Wealth Advisors's LLY Position: Q1 2026 in Review

U.S. Capital Wealth Advisors increased its Eli Lilly (LLY) stake by 103% in Q1 2026, buying an estimated $8.99M and bringing the position to 17,474 shares worth $16.1M. The position accounts for 0.4% of the portfolio, ranked #56.

U.S. Capital Wealth Advisors first reported a position in LLY in Q3 2021 and has held it in 19 quarters since. 4,380 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • U.S. Capital Wealth Advisors held 17,474 shares of Eli Lilly worth $16.1M as of Q1 2026.
  • U.S. Capital Wealth Advisors bought 8,863 Eli Lilly shares in Q1 2026, an estimated $8.99M.
  • Eli Lilly made up 0.4% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #56 holding.
  • U.S. Capital Wealth Advisors first reported a position in Eli Lilly in Q3 2021 and has held it in 19 quarters since.
  • 4,380 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.